Clinical Trials Directory

Trials / Completed

CompletedNCT03525977

Impact of Fascia Iliaca Block in Hip Fracture Patients

Impact of Fascia Iliaca Block on Pain Outcomes and Opioid Consumption for Hip Fracture Patients-A Prospective, Randomized Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
97 (actual)
Sponsor
Texas Tech University Health Sciences Center, El Paso · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Accepted

Summary

The study is a prospective randomized examining the impact of fascia iliaca block on perioperative pain control and post operative ambulation in patients with hip fractures.

Detailed description

Regional anesthesia is an important element of multimodal pain control regimen for surgical patients. Recently, regional anesthesia using a fascia iliaca block (FIB) to help treat pain in patients who present with hip fractures has been gaining popularity and has been incorporated as part of a multi-modal pain control protocol in many centers. It is commonly offered in addition to oral and intravenous medications to help patients deal with pain in the perioperative period. The block is done by an anesthesiologist under anesthesia using ultrasound guidance. We propose a prospective, randomized study evaluating the efficacy of the FIB as an adjunct in the pre-operative or postoperative period for pain control as measured by visual analog scale (VAS) scores and morphine equivalent dosing (MED), as well as its efficacy in promoting patient participation in physical therapy postoperatively in patients who present with hip fractures. We hypothesize that those patients who receive FIBs will report lower VAS scores as well as decreased narcotic requirement at all time points; and have improved participation in therapy when measured by ambulation distance.

Conditions

Interventions

TypeNameDescription
PROCEDUREFascia iliaca block armThe fascia iliaca block will be performed by the anesthesiologist on call

Timeline

Start date
2018-02-20
Primary completion
2019-05-01
Completion
2019-05-01
First posted
2018-05-16
Last updated
2019-05-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03525977. Inclusion in this directory is not an endorsement.